GENE | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

-1.11%

1 Month

7.89%

3 Months

-54.12%

6 Months

-54.82%

1 Year

-95.19%

2 Year

-97.53%

Key data

Stock price

$0.89

P/E Ratio

0.00

DAY RANGE

N/A - N/A

EPS

$0.00

52 WEEK RANGE

$0.69 - $23.25

52 WEEK CHANGE

-$0.96

MARKET CAP

4.315 M

YIELD

N/A

SHARES OUTSTANDING

4.847 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.81

PUBLIC FLOAT

AVERAGE 10 VOLUME

$11,714

AVERAGE 30 VOLUME

$24,700

Company detail

CEO:
Region: US
Website: https://www.gtglabs.com/
Employees: 56
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

genetic technologies (asx: gtg, nasdaq global market: gene) is leading-edge genetic testing and reproductive services business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of dna on health. throughout the asia pacific region, we translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.

GENE - Genetic Technologies Ltd. - ADR